Ingmar Bruns

ZNTL

Ingmar Bruns serves as officer: Chief Medical Officer at Zentalis Pharmaceuticals, Inc. (ZNTL). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

1 trades

$45.7K

Total Sells

2 trades

$16.0K

Net Position

Net Buyer

$29.7K

Companies Traded

ZNTL

Active Period

Feb 2025 – Feb 2026

3 total trades

Most Recent

Sell ZNTL

Feb 10, 2026 · $8.0K

Ingmar Bruns's Insider Trading at Zentalis Pharmaceuticals, Inc. (ZNTL)

Buys

1 · $45.7K

Sells

2 · $16.0K

Total Shares Bought

20,000

Total Shares Sold

6,594

ZNTL Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Feb 10, 2026	Sell	3,297	$2.43	$8.0K	33,667
Feb 6, 2026	Sell	3,297	$2.43	$8.0K	0
Feb 12, 2025	Buy	20,000	$2.28	$45.7K	36,629

Related Insiders

EASTLAND JULIA MARIE

director, officer: CEO & President

ZNTLSell · Feb 10, 2026

Vultaggio Vincent

PAO and PFO

ZNTLSell · Feb 10, 2026

WALTERS GROUP

10% Owner

ZNTLBuy · Dec 31, 2025

Scott Dunseth Myers

Director

ZNTLBuy · Apr 30, 2025

Explore More Insider Trading Data

ZNTL Insider Trading Activity

View all insider trades at Zentalis Pharmaceuticals, Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity